Paranoid psychosis due to flecainide toxicity in malignant neuropathic pain.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9106813.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Flecainide was used to treat malignant neuropathic pain but despite using therapeutic doses, toxicity occurred resulting in paranoid psychosis. Monitoring of flecainide levels in vulnerable populations is suggested to guide prescribing.
Medical subject headings
- Anti-Arrhythmia Agents
- Brachial Plexus
- Flecainide
- Pain
- Paranoid Disorders
- Soft Tissue Neoplasms